E9 Statistical Principles for Clinical Trials
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 16, 1998
April 29, 2020
d427b5ed-dd16-417e-adc2-9f35d3a3df23
Related Documents
Q3C Impurities: Residual Solvents_2011
Guidance DocumentDecember 24, 1997Center for Drug Evaluation and Research
Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products
Guidance DocumentMay 15, 1998Center for Drug Evaluation and Research
Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products
Guidance DocumentJanuary 16, 2003Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox